Friday, 18 December 2020
Autonomic nervous system | nervous system pharmacology | ANS- sympatheti...
Tuesday, 1 December 2020
Classification of neurons | Nervous system
Wednesday, 18 November 2020
Nervous system | Neuron Structure
Saturday, 7 November 2020
Nervous system | cerebrum | Lobes and physiologic regions of the cerebrum
Tuesday, 27 October 2020
Nervous system | Divisions of nervous system | CNS & PNS divisions
Nervous system | Divisions of the nervous system | CNS &
PNS divisions
This video is all about the nervous system’s divisions. The
nervous system is the control centre of our body and it controls the function
either voluntary or involuntary. The nervous system can be divided and
subdivided into many divisions on the basis of anatomy or physiology. The
nervous system is divided into two main divisions: the central nervous system
and peripheral nervous system. The central nervous system is further divided
into the brain and the spinal cord.
The main part of the nervous
system is the brain which is the control centre of the nervous system. The
brain has many divisions for example the forebrain, the midbrain, and the
hindbrain while further each of them is subdivided into different parts and
division. At the lower level, we have different parts of the brain for example
cerebrum (which is further divided into various lobes like frontal lobe,
parietal lobe, temporal lobe, and occipital lobe), cerebellum, midbrain, pons,
and medulla oblongata. While the midbrain, pons, and medulla oblongata is
collectively called the brain stem. The spinal cord is also a part of the central
nervous system and helps in the communication between the brain and the
peripheral nervous system.
The peripheral nervous system comprised of neurons that are
outside of the central nervous system and transfer the signals from the central
nervous system to the periphery or vice versa. The peripheral nervous system is
further divided into two main divisions that are somatic nervous system and
autonomic nervous system.
COVERED TOPICS
Nervous system
Divisions of the nervous system
Central and peripheral nervous system
Brain and spinal cord
Forebrain, midbrain, and hindbrain
Cerebrum, cerebellum, pons and medulla oblongata
Diencephalon and telencephalon
Lobs of the cerebrum
Somatic nervous system and autonomic nervous system
Sympathetic nervous system and parasympathetic nervous
system
Tuesday, 15 September 2020
Biotransformation of drugs -part 4 | cytochrome P450 isozymes | CYP450 i...
subgroups, Depending upon the sequence of amino acid in each isozyme. These enzymes have the capacity to modify a large
number of structurally diverse substrates. In human beings, isozymes that fall
into families CYP1, CYP2, and CYP3 are primarily involved in the metabolism of
most drugs, in which the most active CYPs for drug metabolisms are those in the
CYP2C, CYP2D, and CYP3A subfamilies. In addition, an individual drug may be a
substrate for more than one isozyme. such as tolbutamide, paracetamol,
barbiturates, and nifedipine are substrates for more than one isoform. Which
will be discussed later in this session.
most predominant CYP isoform involved in human drug metabolism, both in terms
of the amount of enzyme in the liver and the variety of drugs that are
substrates for this enzyme isoform. In addition to liver, these isoforms are expressed
in intestine, responsible for first pass metabolism at this site, and kidney as
well. This isoform may account for more than 50% of all CYP-mediated drug
oxidation reactions, and CYP3A4 is likely to be involved in the greatest number
of drug–drug interactions. However, the fact that two drugs are metabolized
predominantly by CYP3A4 does not mean that coadministration will result in a
drug–drug interaction, since drugs can bind in different regions of the CYP3A4
active site, and these regions may be different. In fact, it is believed that two
drugs can occupy the active site simultaneously, with both available for
metabolism by the enzyme. This finding helps account for several absent interactions
that would have been predicted to occur based on strict substrate specificity
rules.
like that of CYP3A4, appears to have approximately the same substrate
specificity characteristics as CYP3A4. However, it differs in that it is not present
in all individuals. Thus, individual expressing both CYP3A4 and CYP3A5 have the
potential to show increased metabolism of CYP3A drug substrates as compared to
individuals expressing only the CYP3A4 isoform. Drugs metabolized by these
isozymes include cyclosporine, simvastatin, HIV protease inhibitors, Ca channel
blockers, hydrocortisone, carbamazepine, midazolam, Losartan, and nifedipine.
isoform is CYP3A7, which appears to be expressed in fetus and rapidly
disappears following birth, to be replaced by CYP3A4 and CYP3A5.
important CYP isoform which metabolizes 25% of the CYP-mediated oxidation
reactions of drugs including tricyclic antidepressants, selective serotonin
reuptake inhibitors, antipsychotic agents, antiarrhythmics, β-blockers and opioid analgesics.
oxidation reactions. This isoform metabolizes several clinically important
drugs with narrow therapeutic margins, two of these drugs is phenytoin and
warfarin, and other drugs like ibuprofen, tolbutamide, repaglinide, celecoxib
and losartan. CYP2C9 appears to prefer weakly acidic drugs as substrates, which
limits the number of drugs metabolized by this isoform since most drugs are
weak bases.
frequently used drugs including omeprazole, lansoprazole, naproxen, diazepam,
and propranolol.
the metabolism of only few drugs like theophylline, caffeine, tacrine,
phenacetin, paracetamol, and carbamazepine.
of only few drugs. like ethanol, halothane, enflurane, and paracetamol.
through these pathways. Few drugs like cimetidine, ranitidine, clozapine are oxidized
by a group of flavin-monooxygenases that are also located at hepatic
endoplasmic reticulum, but are distinct from CYP enzymes. Some other drugs,
e.g. adrenaline, alcohol, mercaptopurine are oxidized by mitochondrial or
cytoplasmic enzymes.
both metabolized by a single CYP, they compete for binding to the enzyme’s
active site. This can result in the inhibition of metabolism of one or both drugs,
leading to elevated plasma levels. If there is a narrow therapeutic index for
the drugs, the elevated serum levels may elicit unwanted toxicities. e.g., a
statin and a macrolide antibiotic or antifungal
Friday, 11 September 2020
Cytochrome P450 enzyme system - Pharmacology
Cytochrome
P450 enzyme system drug metabolism Pharmacology:
Definition and general overview
Cytochrome
P450 enzyme system Also known as microsomal
mixed-function oxidases (MFOs) and cyp450 monooxygenases and simply abbreviated
as CYP, p450 or CYP450 enzymes system.
The CYPs are a superfamily of
isozymes made of haem proteins that catalyzes most of the phase 1
oxidation-reduction processes of drugs metabolic reactions.
The name cytochrome P450 is derived
from the spectral properties of this hemoprotein; In its reduced mean ferrous
form, it bind with carbon monoxide to form a pink compound, which shows maximum
absorption at 450 nm, that’s why they are named as p450,
In humans, over 50 individual P-450s
have been identified but only about 12 are involved in the metabolism of most
drugs. each member of which catalyzes the biotransformation of a unique
spectrum of drugs, with some overlap in the substrate specificities and may act
on the same substrates but at different rates. The only common feature of the
many drugs metabolized by this pathway is lipid solubility.
The CYPs carry out drug metabolism
and metabolize many structurally diverse chemicals. This is due to the multiple
forms of CYPs and the capacity of a single CYP to metabolize many structurally
distinct drugs. In addition, CYPs can metabolize a single compound at different
positions on the molecule. the CYPs are considered unselective to bind and
metabolize multiple substrates.
These enzymes are also responsible
for all or part of the anabolism and catabolism of a number of endogenous
compounds, such as steroid hormones, bile acids and prostaglandins.
Structure
Heme protein of the cytochrome p450
contains one atom of iron in a hydrocarbon cage that functions to bind oxygen
during the reaction. Many other enzymes that use O2 as a substrate for their
reactions contain heme. E.g. hemoglobin.
These enzymes catalyze an oxidation-reduction processes that requires CYP450,
CYP450 reductase, NADPH (reducing agent), and O2.
location
Many drug-metabolizing enzymes are
located in the lipophilic endoplasmic reticulum membranes of the hepatic cells
which has the greatest specific enzymatic activity, and other sites like GIT
and Kidneys.
Nomenclature
CYPs are named with the root CYP
followed by a number appointing the family, a letter denoting the subfamily,
and another number naming the CYP form. Thus, CYP3A4 is family 3, subfamily A,
and gene number 4.
Mechanism of drugs metabolism
These enzymes catalyze reactions
that requires CYP450, CYP450 reductase, NADPH, and oxygen. First of all, in
step 1, P450 containing ferric iron (Fe3+) combines with a molecule of drug
(RH). And form a complex. Subsequently, in second step, NADPH donates an
electron to the flavoprotein P450 reductase, and the flavoprotein is reduced
from oxidized form which in turn reduces the iron to ferrous form (Fe2+), In
third step, it combines with molecular oxygen and subsequently, combines with a
proton and a second electron from flavoprotein P450 reductase to form an
activated oxygen-P450-substrate (Fe2+OOH–RH) complex. This combines with
another proton to yield water with the liberation of oxidized drug from the
complex in the next step and regeneration of P450 enzyme.
In this oxidation-reduction process,
two microsomal enzymes play a key role which are NADPH cytochrome P450
oxidoreductase and cytochrome P450.
In the overall reaction, the drug is
oxidized, and oxygen is reduced to water. The mechanism involves a complex
cycle but the overall net effect of the reaction is quite simple, the addition
of one atom of oxygen to the drug to form a hydroxyl group, the other atom of
oxygen being converted to water.
Cytochrome P-450 catalyzes several reactions, including aromatic and aliphatic hydroxylation reactions, dealkylation at nitrogen, sulfur, and oxygen atoms; heteroatom oxidations at nitrogen and sulfur atoms; reductions at nitrogen atoms; and ester and amide hydrolysis
Thursday, 30 July 2020
cytokine storm and aging | cytokine storm | COVID-19 lecture
MediGuide Lectures, learning with artworks like drawing and calligraphy. In
this lecture, we will discuss the interrelationship between the cytokine storm
and aging. Strangely, plenty of evidence has been shown that the severity of COVID-19
infections vary widely from children usually asymptomatic, adults with a mild infection,
as well as elderly adults appear
to be more severe typically deadly critical. It has proven that COVID-19 infection
in some elderly critical adults leads to a cytokine storm, which is characterized by severe
systemic elevation of several pro-inflammatory cytokines. Then, a
cytokine storm can induce edematous, ARDS, pneumonia, as well as multiple organ
failure in aged patients. It is far from clear till now that why cytokine storm
induced in only COVID-19 elderly patients, and not in young patients. Answer to
this question is it seems that cytokine storm phenomena is associated with age
because Aging is related to
increased levels of systemic pro-inflammatory cytokines and decreased levels of
anti-inflammatory cytokines. Ample studies have indicated elevated levels of
interleukin (IL)-6, IL-1, tumor necrosis factor-α (TNF α), as well as C-reactive protein (CRP) in aged subjects. among
other cytokines, these cytokines are reported to be high in patients with severe
cases of COVID-19. In which IL-6 plays a key role in contributing to cytokine
storm. Accordingly, it seems that increased generation of
pro-inflammatory markers due to SARS-CoV 2 and aging have a critical role in
the process of cytokine storm in severe COVID-19 patients. Although,
the exact underlying mechanism of cytokine storm in elderly adults with severe COVID-19
infection is far from clear. However, It seems that “cytokine storm” the phenomenon in elderly patients with severe COVID-19 infection is associated
with many age-related pathophysiologic processes, including alteration of
angiotensin-converting enzyme 2 (ACE2) receptor expression, excess ROS
production, alteration of autophagy, senescent adipocytes activity mean the
inflammatory phenotype of senescent cell activity, particularly adipose tissue,
and immune-senescence, as well as lack of vitamin D content. Here, we are going
to review and discuss all above mentioned age-related pathophysiological pathways
that appear to contribute to the dysregulation of cytokine networks and
possibly a cytokine storm in elderly patients with severe COVID-19 infection.
will discuss relation between aging and angiotensin‑converting
enzyme 2 receptor (ACE2)
regulator of several physiologic events, including cardiovascular
This system is composed of two different pathways, which have opposing
effects to stimuli which
are angiotensin-converting enzyme (ACE)/angiotensin II (Ang II)/angiotensin
receptor type 1 (AT1) (ACE/Ang II/AT1) pathway; this pathway is related
to tissue injury, inflammation and fibrosis,
is angiotensin-converting enzyme 2 (ACE2)/Ang 1–7/Mas receptor (ACE2/Ang
1–7/Mas) pathway that exerts anti-inflammatory and anti-fibrosis
effects. Recently, it is well accepted that ACE2 on lung epithelial cells are
the entry-point receptors for COVID-19 particles and making it unattainable to
catalyze the reactions. Unfortunately,
several studies identified that ACE2 expression significantly reduces with
aging. These evidences may partially suggest that the increase concentration of
ACE2 receptors in lung epithelial cells in children and young adults may have a
protective effect on severe clinical manifestations due to COVID-19 infection.
Therefore, it is highly likely that low ACE2 expression with aging can lead to
cytokine storm.
the next topic of our lecture is the relation between
low concentrations, and also as a mediator of inflammation at high concentrations.
The main sources of ROS are mitochondrial respiratory chain and NADPH oxidase. It
is suggested that ROS production augment with age and the excess ROS production
in aging can initiate many proinflammatory cytokines generation through activation
of multiple transcription factors, including nuclear factor kappa B (NF-κB), activator protein 1 (AP-1), specificity protein 1 (Sp1), and
peroxisome proliferator-activated receptors (PPARs) and subsequently increased release of pro-inflammatory cytokines,
including; TNF-α, IL-1β, IL-2, and IL-6, as well as adhesion
molecules. Interestingly,
as the excess ROS production can increase pro-inflammatory cytokines, the
pro-inflammatory cytokines can also increase ROS production.
production and inflammation are closely related, which are taking part in the
pathogenesis of chronic inflammation and cytokine storm in elderly adults.
cells by which cellular material delivered into the
maintenance of cellular
homeostasis, and its dysregulation could lead to the development of several
aging-related pathophysiological diseases. It has been shown that the autophagy
process, decrease during aging and leads to the accumulation of damaged
macromolecules and organelles. importantly mitochondria, which is the major
source of ROS result in increased ROS production. In this context, two major processes are for
protection from harmful effects of ROS, including mitophagy and antioxidant capacity.
at one side, mitophagy, which is characterized by autophagic degradation of
mitochondria, decreased with aging. On the other hand, decreased mitophagy, together
with decreased antioxidant capacity during aging can increased ROS levels in
the body. The excess production of ROS leads to increase pro-inflammatory
how the decline in autophagy and a rise in ROS levels during aging can elevate
pro-inflammatory cytokine release is far from clear. However, it is well accepted
that low activity of autophagy process and high level of ROS production during
aging, can activate and upregulate
cytosolic NLRs increased during aging. And can increase the production of
pro-inflammatory cytokines, including IL-1β and IL-18. So, it seems that crosstalk
between
aging can imbalance, immune system activity of
leading to chronic inflammation and organ dysfunction. Senescent cells have
lower cell viability, as well as insufficient protection against oxidative
stress. Adipose tissue is a dynamic structure that plays an important
contribution in modulating of metabolism and inflammation. It is highly likely
that adipose tissue dysfunction in aged obese subjects leads to more serious
complications of COVID-19 as compared to younger individuals. In obese
COVID-19 patients, the adipose tissue interacts with the immune system and
increased the lethality of the infection by fat tissue-associated cytokines or adipokines
which are released. like amyloid-A which acts directly on macrophages and
increases the generation of pro-inflammatory cytokines. Therefore, the elevated
release of pro-inflammatory cytokines by senescence adipocytes possibly leads
to the elevated risk of the cytokine storm in COVID-19 patients.
lecture will be covered in the next video. Make sure you have subscribed our
channel so don’t miss it
Cytokine storm | Cytokine release syndrome | pathophysiology mechanism of CS
The following TOPICS are COVERED in this lecture
cytokine storm or cytokine release syndrome or hypercytokinemia in COVID-19
Mechanism of the pathophysiology of cytokine storm
in normal mean asymptomatic and mild patients
in severe patients
cytokines majorly involved in cytokine storm
Interleukin-6 (IL-6), Tumor necrosis factor-alpha (TNF-a), Interleukin-1B, TGF-B, G-CSF, GM-CSF, Interleukin-17 (IL-17), and other important cytokines
Diagnostic features of cytokine storm
Links:
Also watch:
SARS-CoV-2 || pathophysiology and symptoms of COVID-19
https://youtu.be/B2pRcQ3xUa4
Dexamethasone for COVID-19 | Mechanism of action
https://youtu.be/PIr23fNCOE8
How drugs act
https://www.youtube.com/watch?v=iZLAMgHIH2k
Receptor and its types
https://www.youtube.com/watch?v=-xS5rBJwAKM
Support us on:
Facebook https://web.facebook.com/MK-MediGuide-Lectures-103055758022942/?view_public_for=103055758022942
https://www.twitter.com/Maazkha55086767